Skip to Content
MilliporeSigma
  • Synthesis and accumulation of aromatic aldehydes in an engineered strain of Escherichia coli.

Synthesis and accumulation of aromatic aldehydes in an engineered strain of Escherichia coli.

Journal of the American Chemical Society (2014-07-31)
Aditya M Kunjapur, Yekaterina Tarasova, Kristala L J Prather
ABSTRACT

Aromatic aldehydes are useful in numerous applications, especially as flavors, fragrances, and pharmaceutical precursors. However, microbial synthesis of aldehydes is hindered by rapid, endogenous, and redundant conversion of aldehydes to their corresponding alcohols. We report the construction of an Escherichia coli K-12 MG1655 strain with reduced aromatic aldehyde reduction (RARE) that serves as a platform for aromatic aldehyde biosynthesis. Six genes with reported activity on the model substrate benzaldehyde were rationally targeted for deletion: three genes that encode aldo-keto reductases and three genes that encode alcohol dehydrogenases. Upon expression of a recombinant carboxylic acid reductase in the RARE strain and addition of benzoate during growth, benzaldehyde remained in the culture after 24 h, with less than 12% conversion of benzaldehyde to benzyl alcohol. Although individual overexpression results demonstrated that all six genes could contribute to benzaldehyde reduction in vivo, additional experiments featuring subset deletion strains revealed that two of the gene deletions were dispensable under the conditions tested. The engineered strain was next investigated for the production of vanillin from vanillate and succeeded in preventing formation of the byproduct vanillyl alcohol. A pathway for the biosynthesis of vanillin directly from glucose was introduced and resulted in a 55-fold improvement in vanillin titer when using the RARE strain versus the wild-type strain. Finally, synthesis of the chiral pharmaceutical intermediate L-phenylacetylcarbinol (L-PAC) was demonstrated from benzaldehyde and glucose upon expression of a recombinant mutant pyruvate decarboxylase in the RARE strain. Beyond allowing accumulation of aromatic aldehydes as end products in E. coli, the RARE strain expands the classes of chemicals that can be produced microbially via aldehyde intermediates.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Benzyl alcohol, anhydrous, 99.8%
Sigma-Aldrich
Benzyl alcohol, ≥99%, FCC, FG
Sigma-Aldrich
Chloramphenicol, BioReagent, suitable for plant cell culture
Sigma-Aldrich
Chloramphenicol, ≥98% (HPLC)
Supelco
3,4-Dihydroxybenzoic acid, analytical standard
Supelco
Dimethyl sulfoxide, analytical standard
Protocatechuic acid, primary reference standard
Sigma-Aldrich
Dimethyl sulfoxide, Vetec, reagent grade, 99%
Sigma-Aldrich
Benzyl alcohol, puriss. p.a., ACS reagent, ≥99.0% (GC)
Sigma-Aldrich
Dimethyl sulfoxide, ReagentPlus®, ≥99.5%
Sigma-Aldrich
Benzyl alcohol, puriss., meets analytical specification of Ph. Eur., BP, NF, 99-100.5% (GC)
Supelco
Ampicillin Sodium, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Dimethyl sulfoxide, puriss. p.a., dried, ≤0.02% water
Sigma-Aldrich
Dimethyl sulfoxide, ACS reagent, ≥99.9%
Sigma-Aldrich
Dimethyl sulfoxide, suitable for HPLC, ≥99.7%
Sigma-Aldrich
Dimethyl sulfoxide, puriss. p.a., ACS reagent, ≥99.9% (GC)
Sigma-Aldrich
Benzyl alcohol, ACS reagent, ≥99.0%
Sigma-Aldrich
Benzyl alcohol, ReagentPlus®, ≥99%
USP
Benzyl alcohol, United States Pharmacopeia (USP) Reference Standard
Supelco
Dimethyl sulfoxide, for inorganic trace analysis, ≥99.99995% (metals basis)
Dimethyl sulfoxide, European Pharmacopoeia (EP) Reference Standard
Benzyl alcohol, European Pharmacopoeia (EP) Reference Standard
Supelco
3,4-Dihydroxybenzaldehyde, analytical standard
USP
Sodium benzoate, United States Pharmacopeia (USP) Reference Standard
Supelco
Sodium benzoate, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Ampicillin sodium, United States Pharmacopeia (USP) Reference Standard
USP
Dimethyl sulfoxide, United States Pharmacopeia (USP) Reference Standard
Chloramphenicol, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
3,4-Dihydroxybenzaldehyde, purum, ≥97.0% (HPLC)
Sigma-Aldrich
3,4-Dihydroxybenzoic acid, ≥97.0% (T)